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Abstract: Background: Engagement in cognitively stimulating activities (CA) and leisure time physical activity (PA)
have been associated with maintaining cognitive performance and reducing the likelihood of cognitive decline in older
adults. However, neural mechanisms underlying protective effects of these lifestyle behaviors are largely unknown. In the
current study, we investigated the effect of self-reported PA and CA on hippocampal volume and semantic processing activation during a fame discrimination task, as measured by functional magnetic resonance imaging (fMRI). We also examined whether possession of the apolipoprotein E (APOE) 4 allele could moderate the effect of PA or CA on hippocampal
structure or function. Methods: Seventy-eight healthy, cognitively intact older adults underwent baseline neuropsychological assessment, hippocampal volume measurement via manually-traced structural MRI, and task-activated fMRI.
Results: After 18 months, 27 participants declined by one standard deviation or more on follow-up neuropsychological
testing. Logistic regression analyses revealed that CA alone or in combination with baseline hippocampal structure or
functional activity did not predict the probability of cognitive decline. In contrast, PA interacted with APOE 4 status such
that engagement in PA reduced the risk of cognitive decline in APOE 4 carriers only. Furthermore, the benefits of PA
appeared to diminish with reduced functional activity or volume in the hippocampus. Conclusions: Our findings suggest
that increased leisure time PA is associated with reduced probability of cognitive decline in persons who are at high risk
for AD. The beneficial effects of PA in this group may be related to enhancement of the functional and structural integrity
of the hippocampus.

Keywords: Apolipoprotein E, cognitive activity, cognitive decline, functional magnetic resonance imaging, hippocampus,
physical activity.
INTRODUCTION
The current lack of effective treatments for Alzheimer’s
disease (AD) has stimulated considerable interest in developing strategies for prevention of cognitive decline [1, 2]. A
multidisciplinary expert panel recently reviewed the existing
evidence for such interventions or modifiable risk factors
that may delay AD onset or mitigate cognitive decline [3].
The panel concluded that there is currently insufficient evidence supporting the use of pharmaceutical or nutritional
supplements for preventing AD or cognitive decline. However, the panel also noted positive preliminary data supporting cognitive engagement and physical activity as possible
interventions for maintaining or enhancing cognitive function. A recent report [4] reviewed available evidence and
estimated that approximately half of all AD cases are attributable to modifiable risk factors, including cognitive and
physical inactivity. Indeed, if effective in preventing cogni*Address correspondence to this author at the Schey Center for Cognitive
Neuroimaging, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave. /
U10, Cleveland, OH 44195, USA; Tel.: 216-444-7747; Fax: 216-445-7013;
E-mail: raos2@ccf.org
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tive decline, such lifestyle behaviors have considerable
promise because they are cost-effective and have few adverse side effects.
Participation in cognitively stimulating activities (CA;
e.g., reading, creative writing) has been proposed as a way to
enhance cognitive reserve [5] by promoting resistance to
cognitive decline despite the presence of brain damage or
disease pathology [6]. Longitudinal epidemiological studies
have demonstrated that participation in CA is associated with
a reduced incidence of cognitive decline in late life [7-9],
mild cognitive impairment (MCI) [10], and AD [5, 11-15].
CA has also been associated with superior cognitive functioning in healthy older adults [16, 17]. Despite numerous
epidemiological studies showing benefits of CA for maintaining cognitive function, a biological mechanism for these
effects remains elusive. Increased blood flow and metabolism to the brain during CA or the effects of repetitive behavioral rehearsal are possible explanations. However, effects of
CA on brain structure or function have not been systematically examined. While the broader construct of cognitive
reserve involves enhanced neural network efficiency associated with increasing task difficulty [6], no imaging studies
© 2012 Bentham Science Publishers
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have looked specifically at the impact of CA on neural functioning.
Engagement in leisure-time physical activity (PA) is another common lifestyle modification for managing and preventing a variety of chronic health conditions (e.g., hypertension, obesity, diabetes) [18-20]. However, it may also play a
role in reducing likelihood of cognitive decline [21]. Longitudinal epidemiological studies suggest that late-life participation in PA (e.g., walking, calisthenics) is associated with a
reduced incidence of cognitive decline [22-29], MCI [30],
and AD [14, 22, 31-34], and intervention studies have demonstrated that engagement in PA can improve cognitive and
attentional task performance [35-37]. One recent report [38]
suggested that engagement in PA may also be associated
with prolonged survival in AD patients. Animal models have
suggested possible biological mechanisms underlying the
positive effects of PA on cognitive function. For example,
PA may enhance neural functioning by increasing levels of
brain-derived neurotrophic factor (BDNF), which in turn
mediates synaptogenesis, neurogenesis, and plasticity [39,
40]. Exercise interventions can stimulate hippocampal neurogenesis in rodents [41-48]. These enhancements may lead
to more efficient brain functioning and confer resistance to
future cognitive decline. Importantly, several studies have
suggested that the beneficial effects of PA may be moderated
by the presence of one or both apolipoprotein E (APOE) 4
alleles, a well-established risk factor for AD. In several studies, PA appears to exert a greater protective effect for 4
carriers than for non-carriers [23, 31, 49]. In contrast, another study found PA preferentially benefits APOE 4 noncarriers [32]. Thus, the nature of the association between PA
and cognitive decline, and how the APOE 4 allele influences this relationship, are unclear.
Functional neuroimaging studies evaluating lifestyle
modifications, such as PA and CA, may elucidate biological
mechanisms by which these interventions confer resistance
to late-life cognitive decline. Several of the previously discussed animal studies suggest that biological changes in the
hippocampus may underlie some of the benefits of interventions such as PA. The purpose of the current study was to
evaluate whether PA and CA may reduce the risk of cognitive decline independent of hippocampal volume and function. We used a famous name discrimination task during
functional magnetic resonance imaging (fMRI) that has consistently revealed greater semantic processing activity in
persons at-risk for AD (cognitively intact older APOE 4
carriers [50] and persons with MCI [51]) relative to persons
not at-risk. A longitudinal follow-up study using this task
demonstrated that healthy older adults with greater baseline
semantic processing activity in cortical and hippocampal
regions and larger baseline hippocampal volumes (particularly in APOE 4 carriers) showed greater stability in cognitive functioning over 18 months [52]. In a subsequent crosssectional study, persons who reported engaging in regular
PA exhibited greater cortical semantic processing activity on
this task, particularly among APOE 4 positive participants
[53]. Thus, the current study was designed to extend the results of these previous studies by comparing the effects of
PA, CA, and hippocampal activity and volume on cognitive
decline. Because we observed the protective effect of in-
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creased semantic processing activation to be strongest in
APOE 4 allele carriers [52] and because PA was associated
with the greatest increase in semantic processing activation
for APOE 4 allele carriers [53], we predicted that the presence of the APOE 4 allele and increased hippocampal
activation would potentiate the protective influences of PA
or CA on resistance to cognitive decline.
MATERIAL AND METHODS
Participants
Participants were recruited via newspaper advertisements. In order to enrich our sample with participants who
were at-risk for AD, half of the participants were selected on
the basis of having a family history of dementia, defined as
having a first-degree relative with a formal diagnosis of AD
prior to death or a reported history of dementia-like symptoms without a diagnosis. Because of the elevated proportion
of individuals with a family history of dementia, the representation of APOE 4 carriers was also greater in our sample
than in the general population.
Participants were required to be cognitively intact and
non-demented upon study entry. They were excluded if they
scored less than 25 on the Mini-Mental State Exam (MMSE)
[54] or more than 1.5 standard deviations below ageappropriate means on the Rey Auditory Verbal Learning
Test (RAVLT) [55]; Mattis Dementia Rating Scale-2
(MDRS-2) [56-58]. Participants were also excluded if they
obtained a score greater than 10 on the Geriatric Depression
Scale (GDS) [59, 60] “or” if they demonstrated any impairment of activities of daily living on the Lawton and Brody
Self-Maintaining and Instrumental Activities of Daily Living
Scale [61]. Finally, participants were excluded if they had a
history or evidence of: 1) significant neurological illnesses/conditions; 2) medical illnesses/conditions that may
affect brain function; 3) current psychiatric disturbance or
substance abuse or dependence meeting DSM-IV Axis I
criteria; 4) contraindications specific to MR scanning: pregnancy, weight inappropriate for height, ferrous objects within
the body, or a history of claustrophobia; 5) left-handedness
or ambidexterity (laterality quotient [LQ] < 50) as assessed
with the Edinburgh Handedness Inventory [62]; or 6) use of
medications that may affect the hemodynamic response in
the scanner.
Seventy-eight community-dwelling older adults meeting
study inclusion and exclusion requirements served as study
participants (Table 1). Family history of dementia was present in 51.3% of participants; 33.3% of the sample carried
the APOE 4 allele. One participant was a homozygous carrier of the 4 allele; the remaining 25 carriers were heterozygous (3, 4). Among the non-carriers, there were 44 persons
who were homozygous 3 carriers and 8 persons who were
heterozygous (2, 3). At baseline, all participants completed
the PA survey, but three participants did not complete the
CA survey. Baseline neuropsychological evaluation revealed
that all participants were initially cognitively intact according to the measures described above. All participants were
Caucasian. Written informed consent was obtained and all
participants received financial compensation for time and
travel.

Lifestyle and Genetic Contributions to Cognitive Decline
Table 1.
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Means (and SDs) of Demographic and Neuropsychological Test Results for Stable and Declining Participants. SDs are Provided in
Parentheses

Variable

Stable (n=51)

Declining (n=27)

72.6 (5)

73.6 (4.7)

15.1 (2.4)

14.5 (3.2)

551.7 (43.5)

560.6 (47.0)

100% Caucasian

100% Caucasian

Family History Status

27 Dementia -, 24 Dementia +

11 Dementia -, 16 Dementia +

APOE allele status*

39 4- (5 23, 34 33),
12 4+ (11 34, 1 44)

13 4- (3 23, 10 33),
14 4+ (all 34)

13 Males, 38 Females

8 Males, 19 Females

25.9 (2.8)

26.7 (2.8)

25 Low PA, 26 High PA

16 Low PA, 11 High PA

DRS-2 Total

140.7 (3.2)

139.7 (3.8)

RAVLT Trials 1-5

50.6 (8.8)

46.8 (8.1)

RAVLT DR

10.1 (2.6)

9.0 (2.8)

5 (0)

5 (0)

GDS*

2.7 (2.5)

1.4 (1.8)

MMSE

29.4 (0.8)

28.9 (1.2)

DRS-2 Total**

139.5 (2.1)

135.6 (5.0)

RAVLT Trials 1-5**

49.5 (7.5)

40.1 (7.1)

RAVLT DR**

10.2 (2.4)

6 (2.3)

Lawton IADL

4.98 (0.14)

4.96 (0.19)

GDS*

2.6 (2.6)

1.3 (1.8)

MMSE

29.5 (1.1)

29.0 (1.2)

Age (years)
Education (years)
Test-Retest Interval (days)
Ethnicity

Gender
Cognitive Activity (Sum)
Physical Activity
Baseline Cognitive Results

Lawton IADL

Follow-up Cognitive Results

Note: IADL=Instrumental Activities of Daily Living; GDS=Geriatric Depression Scale; MMSE=Mini-Mental State Examination; DRS-2=Mattis Dementia Rating Scale-2;
RAVLT=Rey Auditory Verbal Learning Test; *p<.05 between-groups. **p<.001.

Neuropsychological Assessment and APOE Genotyping
Participants underwent baseline neuropsychological testing, fMRI scanning, and APOE genotyping. The neuropsychological battery included the MMSE, GDS, MDRS-2,
RAVLT, and Lawton Instrumental Activities of Daily Living
Scale. Each of these measures is commonly used in dementia
assessment. The MMSE is a brief, 30-point measure of cognitive status. The GDS is a 30-item measure of the presence
or absence of depressive symptoms that has been well validated with older adults. The MDRS-2 provides an index of
global cognitive functioning as well as domain-specific performance measures in five cognitive domains (Attention,
Initiation/Perseveration, Construction, Conceptualization,
and Memory). The RAVLT consists of a list of 15 unrelated
words that is presented to the participant over five study-test
trials. In order to test susceptibility to proactive and retroac-

tive interferences, a distractor list of words is then presented
in a study-test format, followed by a trial requiring the participant to recall the original list of words. Finally, 30-minute
delayed recall and recognition of the original list are assessed. Although the RAVLT provides a number of memory
performance indices, the current study examined the Sum of
Words Recalled across Trials 1-5 (a measure of immediate
learning capability) and 30-minute Delayed Recall (as a
measure of delayed retention). Finally, the Lawton Instrumental Activities of Daily Living Scale evaluates the extent
of functional independence by surveying capacity to carry
out both instrumental and personal self-maintenance activities of daily living. APOE genotype was determined from
whole blood using a PCR method [63]. An 18-month followup neuropsychological evaluation was completed using alternate forms of the DRS-2 [64, 65] and RAVLT [66].
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PA Survey

fMRI Task

Participation in PA was assessed at baseline with the
Stanford Brief Activities Survey "(SBAS; [67])” which has
been validated for assessment of habitual PA in older adults
[67, 68] and has shown significant, dose-dependent relationships with cardiovascular risk factors and estimated energy
expenditure in a large sample [67]. Survey items pertained to
PA performed over the previous year. Participants who reported two or fewer instances of low intensity PA (e.g., going for walks, doing chores, or playing golf) per week were
assigned to the low PA group. Participants who reported
moderate (e.g., brisk walking for 15 minutes; performing
moderately difficult chores for 45 minutes) to heavy (e.g.,
jogging for 30 minutes; moderately difficult chores for 60
minutes) PA at least three times a week were assigned to the
high PA group. The group designation criteria for the high
PA group are roughly consistent with the recommendations
for minimum physical activity participation in healthy older
adults that are expected to confer health benefits, while the
low PA group did not meet this recommendation [20].

For the famous name discrimination task [72], participants viewed individually presented names of well-known
public figures (famous) or names drawn at random from a
local telephone book (unfamiliar). Stimuli consisted of 30
famous and 30 unfamiliar names that were randomly interspersed with 20 presentations of a centrally placed crosshair
to introduce “jitter” into the fMRI time course. Stimuli were
presented using a fixed interstimulus interval of 4 sec. The
imaging run started and ended with 12 secs of fixation. Total
time for the single imaging run is 5 min and 24 sec. By using
an event-related fMRI design, we are able to exclude the
occasional incorrect item from the derived activation maps
and avoid other methodological concerns associated with a
blocked design format (e.g., strategy deployment). Participants made a right index or right middle finger key press for
famous or unfamiliar names, respectively. Accuracy and
reaction time were recorded.

CA Survey
Participation in CA was assessed at baseline using the
Cognitive Activities Scale “(CAS; [17])” a previously established composite index of CA frequency [7, 11, 12, 17]. Participants were asked about their frequency of participation in
seven cognitively stimulating activities: viewing television,
listening to radio, reading newspapers, reading magazines,
reading books, playing games (e.g., cards, checkers, crosswords, puzzles), and going to museums. Participants used a
five-point Likert-type rating scale to indicate their current
frequency of participation for each activity, where 5 = every
day or about every day, 4 = several times a week, 3 = several
times a month, 2 = several times a year, and 1 = once a year
or less. Scores from all seven activities were summed to
form a composite index of participation in CA, ranging from
7 to 35.
Definition of Cognitive Decline
Significant cognitive decline was defined as exhibiting a
one SD reduction or greater on at least one of the three principal outcome indices (DRS-2, RAVLT Sum of Trials 1-5,
RAVLT Delayed Recall). Standardized residual change
scores were computed [52] to adjust for baseline performance, practice effects, and regression to the mean [69-71].
Participants with standardized residual scores of -1.0 or
lower for at least one neuropsychological measure constituted the cognitively declining group; the remaining participants were classified as cognitively stable. Because age may
influence the likelihood of cognitive decline, age-corrected
scores on each of these measures were also used to compute
standardized residual change scores. The results using agecorrected residual change scores did not differ from noncorrected change scores, which may have been a function of
the relatively brief test-retest interval of 18 months. Therefore, our definition of cognitive decline in the analyses that
follow used residual change scores that are not corrected for
age.

Image Acquisition
Whole-brain, event-related fMRI was conducted on a
General Electric (Waukesha, WI) Signa Excite 3.0 Tesla
short bore scanner equipped with a quad split quadrature
transmit/receive head coil. Echoplanar images were collected
using an echoplanar pulse sequence (TE=25 ms; flip angle=77 degrees; field of view (FOV)=24 cm; matrix size=64
x 64; TR=2 secs). Thirty-six contiguous axial 4-mm-thick
slices provided whole brain coverage (voxel size = 3.75 x
3.75 x 4 mm). High-resolution, three-dimensional spoiled
gradient-recalled at steady-state (SPGR) anatomic images
were acquired (TE = 3.9 ms; TR = 9.5 ms; inversion recovery (IR) preparation time = 450 ms; flip angle = 12 degrees;
number of excitations (NEX) = 2; slice thickness = 1.0 mm;
FOV = 24 cm; resolution = 256 x 224). Foam padding was
used to reduce head movement within the coil.
Hippocampal Activation
Functional images were generated with the Analysis of
Functional NeuroImages (AFNI) software package [73].
Each image series was time-shifted to the beginning of the
TR and spatially registered to reduce head motion effects
using a rigid body iterative linear least squares method. A
deconvolution analysis was used to extract separate hemodynamic response functions (HRFs) for correctly recognized
famous and unfamiliar names. HRFs were modeled for the 016 second period post-stimulus onset. Motion parameters
and incorrect trials were incorporated into the model as nuisance regressors. Area under the curve (AUC) was calculated
by summing the hemodynamic responses at time points 4, 6,
and 8 seconds post-trial onset. Anatomical and functional
scans were transformed into standard stereotaxic space [74],
and functional images were blurred using a 6-mm Gaussian
filter.
A voxelwise t-test contrasting semantic activation during
correct discrimination of famous names versus unfamiliar
names (AUCs) was performed on all participants. The statistical threshold was based on an individual voxel probability
(p = 0.005) coupled with a minimum cluster volume (0.73
ml). These values were derived from 3,000 Monte Carlo
simulations [75] and correspond to a whole brain family-
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wise error threshold of p < 0.05. This approach identified
significant clusters representing functional regions of interest
(fROIs; [52]). Across all voxels within each fROI, an “average AUC” was computed for each participant. Using these
data, a principal components analysis (PCA) further reduced
the number of regions that would serve as predictors in the
logistic regression analysis. Two components were identified, representing cortical (bilateral posterior cingulate/ precuneus, left angular gyrus, left superior frontal gyrus, right
angular gyrus, right superior middle frontal gyrus) and hippocampal (right and left parahippocampal gyrus/ hippocampus) regions of increased semantic activation during correct
identification of famous names relative to unfamiliar names.
Because this study focused on hippocampal volume and
function, only the latter component was used in logistic regression models.
Hippocampal Volume
Left and right hippocampal volumes were obtained using
Freesurfer [76, 77] and manually edited on T1-weighted
SPGR images by two raters blinded to participant group
membership as described previously [52]. Hippocampal volumes were normalized by dividing by the total intracranial
volume. Intraclass correlation for the two raters was 0.87.
The left and right hippocampal volumes were then summed
to create a single value.
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ropsychological scores in Table 1 reveal that the declining
group clearly demonstrated significant reductions on all three
of the measures used to define the groups (DRS-2, RAVLT
Sum of Trials 1-5, and RAVLT Delayed Recall). There was
no significant change in the level of depressive symptoms
reported on the GDS over the two assessments.
Influence of CA and PA on Cognitive Decline
Table 2 shows the results of several logistic regression
models investigating how well CA, APOE 4 allele status,
hippocampal volume, and fMRI-measured semantic processing activity help predict probability of cognitive decline after
18 months. Each model’s ability to discriminate between
stable and declining participants was evaluated with
Nagelkerke R2 and the concordance or C index (related to the
area under the receiver operating characteristic curve; [78]).
The Nagelkerke R2 reflects the collective importance of the
predictors in each model as compared to a “perfectly fitting”
null model [79]. The C index reflects the proportion of all
possible pairs of declining and stable subjects in which the
declining participant in the pair had a higher predicted probability of decline than the stable participant [78].
Baseline Models

We tested two initial logistic regression models that predicted cognitive decline at 18-month follow-up using APOE
4 allele status, either baseline PA or CA, and the APOE 4
allele status by activity interaction. Next, we tested several
logistic regression models to determine whether addition of
the baseline neuroimaging variables as covariates would
enhance prediction of cognitive decline beyond APOE 4
allele status and participation in CA or PA alone.

Two baseline models were established in order to assess
the combined influence of factors other than CA and PA that
might also be predictive of cognitive decline at 18-month
follow-up. These models included APOE 4 allele status and
either baseline hippocampal fMRI semantic processing activity (Model 1A) or baseline hippocampal volume (Model 1B).
Although both models exhibited comparable C indices (.72),
the model that included APOE 4 allele status and hippocampal fMRI activity yielded a slightly stronger R2 (.203).
Models assessing the impact of CA and PA on cognitive
decline at follow-up were contrasted against these baseline
models.

RESULTS

Effect of CA on Cognitive Decline

Demographics and Baseline and Follow-up Neuropsychological Scores

A logistic regression model that included only APOE 4
allele status, participation in CA and the interaction between
these two variables (Model 2A) was not statistically significant. For Model 2B, which added baseline hippocampal
fMRI semantic processing activity as a covariate, only the
hippocampal fMRI index emerged as a significant predictor.
For Model 2C, there were no significant effects, although
baseline hippocampal volume demonstrated a non-significant
trend (p=.07) toward significance. For Models 2B and 2C,
addition of the neuroimaging variables enhanced the C index
and R2 values relative to Model 2A. Because these increases
were principally driven by the neuroimaging variables, it
does not appear that participation in CA affects the predicted
probability of cognitive decline. In addition, relative to the
two baseline models (Models 1A and 1B), the models that
added CA and its interaction with APOE 4 allele status did
not result in appreciably different C indices or R2 values.

Data Analysis

Twenty-seven of the 78 participants demonstrated a one
SD decline on one or more of the three principal neuropsychological measures (DRS-2, RAVLT Sum of Trials 1-5,
RAVLT Delayed Recall). Participant demographics, neuropsychological performance, PA and CA data for the
stable (n=51) and declining (n=27) groups are presented in
Table 1. Importantly, there were no significant differences
between the stable and declining groups on age, education,
or gender representation. There was a non-significant trend
for the declining group to have slightly lower baseline scores
on the MMSE, RAVLT Sum of Trials 1-5, and RAVLT Delayed Recall relative to the stable group. The stable group
demonstrated significantly greater baseline mean scores on
the GDS, although neither the stable nor declining groups
scored in the clinical range on this measure. Although there
was a significantly higher proportion of APOE 4 carriers in
the declining group, there were no significant differences
between groups with respect to other demographic variables
or extent of engagement in PA or CA. At follow-up, the neu-

Effect of PA on Cognitive Decline
The logistic regression model that included PA (high vs.
low), APOE 4 allele status, and their interaction (Model
3A) was statistically significant. APOE 4 allele status and
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Logistic Regression Results Testing Effects of Neuroimaging Results, APOE 4 Allele Status, and Physical or Cognitive
Activity on Cognitive Decline

Baseline Model 1A
Effect

R2=.203

C=.719

Baseline Model 1B

Coefficient

SE

Wald Z

p

Intercept

-1.23

0.35

-3.54

4E-4

Hippocampal fMRI

-0.70

0.31

-2.23

APOE 4 genotype

1.40

0.54

2.60

Coefficient

SE

Wald Z

p

Intercept

3.30

2.16

1.52

.127

.025

Hippocampal volume

-0.99

0.49

-2.02

.043

.009

APOE 4 genotype

1.06

0.53

-2.00

.045

Cognitive Activity Models
Model 2A
Effect

Physical Activity Models
R2=.104

C=.640

Model 3A

Coefficient

SE

Wald Z

p

Intercept

-1.01

0.41

-2.45

.014

APOE 4 genotype

0.61

0.77

0.79

CA level

-0.09

0.66

APOE 4 genotype * CA
level

0.90

1.06

Model 2B
Effect

SE

Wald Z

p

Intercept

-1.19

0.432

-2.76

.006

.429

APOE 4 genotype

2.69

0.893

3.02

.003

-0.13

.895

PA status

0.21

0.645

0.32

.746

0.84

.399

APOE 4 genotype * PA
level

-2.41

1.152

-2.09

.037

R2=.209

C=.724

Model 3B

SE

Wald Z

p

Intercept

-1.09

0.43

-2.51

.012

Hippocampal fMRI

-0.72

0.32

-2.28

APOE 4 genotype

0.63

0.79

CA level

-0.20

APOE 4 genotype * CA
level

1.17

Effect

Effect

R2=.208

C=.680
Coefficient

Coefficient

Model 2C

Effect

R2=.178

C=.716

Coefficient

SE

Wald Z

p

Intercept

-1.42

0.47

-3.01

.003

.023

Hippocampal fMRI

-0.81

0.35

-2.29

.022

0.79

.428

APOE 4 genotype

3.04

0.96

3.17

.002

0.69

-0.29

.773

PA level

0.36

0.68

0.53

.597

1.12

1.04

.296

APOE 4 genotype * PA
level

-2.75

1.22

-2.24

.025

R2=.163

C=.703

Effect

R2=.304

C=.741

Model 3C

Coefficient

SE

Wald Z

p

Intercept

2.92

2.18

1.34

.181

Hippocampal volume

-0.90

0.50

-1.81

APOE 4 genotype

0.56

0.78

CA status

0.09

APOE 4 genotype * CA
level

0.67

Coefficient

SE

Wald Z

p

Intercept

3.02

2.37

1.27

.202

.070

Hippocampal volume

-0.93

0.52

-1.78

.075

0.72

.474

APOE 4 genotype

2.36

0.92

2.56

.011

0.68

0.13

.897

PA level

-0.01

0.67

-0.02

.985

1.09

0.62

.538

APOE 4 genotype * PA
level

-2.08

1.18

-1.76

.079

the interaction between PA and APOE 4 status were significant predictors. Inspection of the simple effects of this
interaction revealed that the predicted probability of decline
for the APOE 4 positive participants who reported low PA
was significantly higher compared to APOE 4 carriers who
reported high PA. However, the predicted probability of decline was not affected by PA level for APOE 4 negative
participants Fig. (1).
For models 3B and 3C, we added indices of baseline hippocampal function and structure as covariates to determine
their relationship with prediction of cognitive decline at
18-month follow-up when combined with APOE 4 allele

Effect

R2=.258

C=.742

status and PA level. Relative to Model 3A, addition of the
neuroimaging covariates increased the Nagelkerke R2 and C
index values by 5-10%, depending on the model. For Model
3B, APOE 4 allele status and baseline hippocampal fMRI
semantic activation were significant predictors of decline.
For Model 3C, although APOE 4 allele status was a significant predictor, total hippocampal volume at baseline demonstrated a non-significant trend (p=.075) as a covariate. For
both Models 3B and 3C, the main effect of PA status was not
significant. However, the interaction between PA and APOE
4 status was significant in Model 3B (p=.032) but demonstrated a non-significant trend in Model 3C, where baseline
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total hippocampal volume was included as a covariate
(p=.079).
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physical inactivity is not significantly different when baseline hippocampal volume is held constant at 2 SD above or
below the mean.
DISCUSSION

Fig. (1). Differences between predicted probabilities of decline for
high and low PA groups as a function of APOE 4 allele status.
Error bars reflect the 95% confidence intervals. Low PA 4 carriers
(n=11) demonstrated a higher probability of decline than low PA 4
non-carriers (n=30), high PA 4 carriers (n=15), and high PA 4
non-carriers (n=22).

To better elucidate the interaction between PA and APOE
4 allele status in Model 3B, we held the covariate (baseline
hippocampal fMRI semantic processing activity) constant at
the mean and at several 0.5 SD increments above and below
the mean. Then, for APOE 4 positive and negative individuals separately, we plotted the differences between the
predicted probabilities of decline for high and low PA participants. The upper two graphs in Fig. (2) display the difference in predicted probabilities of decline for the low PA
group minus the high PA group at each incremental level of
baseline hippocampal activity.
For APOE 4 negative participants (Fig. (2), upper left
panel), there was no significant difference between the predicted probabilities of decline for high and low PA participants. However, for APOE 4 positive participants (Fig. (2),
upper right panel), the predicted probability of decline associated with low PA is significantly higher than that for high
PA. Further inspection suggests that the relative advantage
conferred by PA in reducing the probability of cognitive
decline decreases as hippocampal fMRI semantic processing
activity decreases from values that are 0.5 SD above the
mean. Smaller PA-related differences in predicted probability of decline were also seen as fMRI semantic processing
activity increased above 0.5 SD beyond the mean. Importantly, there were no significant differences in predicted
probability of decline for high and low PA participants when
hippocampal semantic processing activity was 2 SD above or
below the mean.
Although the overall interaction was not significant, Fig.
(2) (lower two panels) demonstrates similar trends for baseline hippocampal volume. The protective effect of PA over

Our major finding is that high PA was associated with a
reduced likelihood of cognitive decline in APOE 4 carriers.
In contrast, PA level did not influence the probability of decline in APOE 4-negative participants. Moreover, greater
engagement in PA tended to confer progressively smaller
advantages over low PA as hippocampal fMRI semantic
processing activity decreased. That is, as hippocampal function declines, the effectiveness of PA as an intervention
against cognitive decline may become attenuated. A similar
trend was seen with smaller baseline hippocampal volumes.
These findings suggest the importance of beginning a PA
regimen as early as possible, prior to the occurrence of substantial hippocampal volume or functional activity loss that
might be attributable to disease-related factors. In addition,
higher levels of hippocampal fMRI semantic processing activity were also associated with smaller differences in predicted probability of decline between the high and low PA
groups. This finding could be attributable to the effects of
cognitive reserve, suggesting that greater levels of hippocampal integrity may buffer against cognitive decline [6]. In
addition, PA may play a neuroprotective role by reducing
age-related declines in gray and white matter density [80]
and hippocampal atrophy [35]. Individuals with intact and
highly functional hippocampi may be at lower risk of cognitive decline regardless of their PA level [81-86].
High and low PA APOE 4 non-carriers did not show
any difference in predicted probability of decline, regardless
of fMRI semantic processing activity or baseline hippocampal volume. While generally beneficial associations between
PA and cognitive functioning have been reported in humans,
other studies have reported null findings [5, 11-13, 87]. Our
findings are consistent with results from a study showing
that a lack of PA posed a greater risk of cognitive decline in
older male APOE 4 carriers than non-carriers [23]. In addition, our results support findings that midlife physical activity was associated with greater reductions in the risk of incident dementia and AD in APOE 4 carriers relative to noncarriers after an average follow-up of 21 years [31]. In contrast, in a large, population-based study, lack of PA was associated with an increased number of incident dementia
cases only in APOE 4 non-carriers [32]. Important differences between this study and ours that could account for the
apparent discrepant effects of PA in APOE 4 non-carriers
include outcome measure (e.g., cognitive decline vs. incident
dementia), timing and duration of PA, and the approach used
to assess PA. These methodological differences will be important to examine in future research.
Finally, participation in CA was not predictive of subsequent cognitive decline in our logistic regression models.
This finding contrasts with results from a prior study utilizing the CAS [7]. However, in that study, the sample size was
very large (n = 4392), follow-up occurred over a longer time
frame than in the current study (average follow-up: 5.3 years
vs. 18 months), and cognitive decline was coded as a con-
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Fig. (2). (upper two graphs). Simple effects of the APOE 4 * PA interaction, holding hippocampal fMRI semantic processing activity constant at selected values 2 SD above and below the mean. Closed circles represent the predicted probability of decline for the low PA group
minus the predicted probability of decline for the high PA group, and error bars reflect the 95% confidence intervals. Note that there is no
significant difference between predicted probabilities of decline for low and high PA participants for hippocampal fMRI activity values at +2
and -2 SD from the mean. The difference between predicted probabilities of decline for high and low PA participants appears to be greatest
at 0.5 SD above the mean and becomes smaller as hippocampal activity values decrease (possibly reflecting the loss of hippocampal function) or increase (possibly reflecting the effects of cognitive reserve). Fig. (2) (lower two graphs). Simple effects of the APOE 4 * PA interaction, holding hippocampal volume constant at selected values 2 SD above and below the mean. Closed circles represent the predicted
probability of decline for the low PA group minus the predicted probability of decline for the high PA group, and error bars reflect the 95%
confidence intervals. Note that there is no significant difference between predicted probabilities of decline for high and low PA participants
for hippocampal volumes that are +2 SD from the mean, and the difference approaches 0 for hippocampal volumes that are -2 SD from the
mean. As in the upper two graphs, the difference between predicted probabilities of decline for low and high PA participants appears to be
greatest at 0.5 SD above the mean and becomes smaller as hippocampal volumes decrease (possibly reflecting the loss of hippocampal function) or increase (possibly reflecting the effects of cognitive reserve).

tinuous rather than a dichotomous variable, utilizing a composite z-score from four tests of cognitive function [7].
Our results complement the findings of a recent study
[35] demonstrating that a one-year PA intervention can increase hippocampal volume in older adults. Specific PAassociated improvement in spatial memory was associated
with increased volume of the anterior hippocampus. Our
study extends these results by directly examining the longitudinal effects of both CA and PA on risk for cognitive decline using both sMRI , fMRI and by focusing on APOE 4
allele as a moderator of the relationship between cognitive
decline and hippocampal structure and function. Future interventional research should examine whether different intensities of PA exert varying effects on hippocampal volume
and function and whether they have differential impacts on
the trajectory of cognitive decline. Additionally, future studies might investigate whether the benefits of PA interventions are reduced in asymptomatic elders with below average
hippocampal volume and/or functional integrity, as suggested by our results.

Although this study represents the first to incorporate
both functional and anatomical brain imaging to assess the
effects of lifestyle and genetic risk on cognitive functioning,
limitations of our study should be considered. Our sample
size and relatively brief follow-up period may have limited
our ability to detect a relationship between cognitively
stimulating activities and cognitive decline. A more expanded survey of CA, including activities such as playing
musical instruments, going to classes, studying, painting,
cooking food, and going to theatres or concerts, may provide
greater sensitivity to predicting cognitive decline [10, 13-15,
88-91]. Additionally, in our study, we dichotomized participants into high and low PA groups; other PA questionnaires
estimate energy expenditure during PA as a continuous variable [92-95]. An even better approach would involve the use
of accelerometry to objectively measure PA or the prospective engagement in a controlled physical exercise training
program.

Lifestyle and Genetic Contributions to Cognitive Decline

CONCLUSION
Results of our study revealed that engagement in leisuretime PA, but not CA, is associated with a reduced probability
of cognitive decline over 18 months in healthy older APOE
4 carriers. Furthermore, addition of baseline fMRI semantic
processing activity or baseline hippocampal volume as covariates enhanced prediction of future decline. We did not
find an effect of participation in PA or CA on risk of cognitive decline in APOE 4 non-carriers. When the simple effects of the APOE 4 allele status by PA interaction were
examined, the difference between the predicted probabilities
of decline for high and low PA APOE 4 carriers decreased
with lower levels of hippocampal fMRI semantic processing
activity and hippocampal volume. This trend may suggest
decreasing benefits of PA in persons with lower levels of
hippocampal function or reduced hippocampal volume.
Smaller differences in predicted probability of decline for the
two PA groups were also observed with greater hippocampal
volume or higher levels of hippocampal fMRI activity. This
finding suggests that greater hippocampal volume and function reflect greater cognitive reserve and buffer against cognitive decline [6].
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